Furthermore, our findings indicated that elevated HuR levels were associated with poorer OS, DSS, DFI, and PFI across various cancer types (including ACC, BRCA, GBM-LGG, KICH, LGG, LIHC, LUAD, MESO PAAD, SARC, SKCM, and UVM), suggesting that HuR holds potential as a prognostic indicator for survival outcomes among cancer patients. The gene discussed is ELAVL1; the disease is glioblastoma.